ResMed’s two new headwinds: weight-loss drugs and a returning rival
Our stock picking expert says ResMed is a quality business now facing two new headwinds. Here's what it has to overcome.
Expert analysis and insights on investing from our team of specialists.
Our stock picking expert says ResMed is a quality business now facing two new headwinds. Here's what it has to overcome.
Suburbs with a higher share of owner-occupied homes recorded significantly stronger long-term capital growth between 2010 and 2026, driven by a 34-percentage point performance gap…
How exactly has Trump earned so much money from cryptocurrency?
1 July is the day a swag of new rules kick in. Here's what will hit your portfolio, your tax and your hip pocket on…
The federal Budget was sold as good news for first home buyers. And maybe it is. But for the millions of Australians who already own…
Wine, watches and Hermès handbags get talked about as a serious place to park money. But do investments in luxury goods stack up? I took…
It's a case of 'buyer-beware' on markets these days when massive companies like SpaceX IPO and come up for trading. Here's why.
SpaceX is about to pull off what is set to be the biggest sharemarket float in history. But here's why this strategist we spoke to…
Wesfarmers chief executive Rob Scott says artificial intelligence will lift productivity across Bunnings, Kmart, Officeworks and the chemicals arm thanks to its data. What does…
Could retirees restructure their affairs, qualify for a pension and avoid the new tax? Or is this another example of a technically possible strategy that’s…